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B<tckgrOund Not all antlhyportons~ve treatments have the predicted benohoal 
effect on athomsclorebc vascular disease and ins may be due to their 
tadure to regulate endothohal cell dysfunction associated to hyportons~an, 
E-Seloctin, a sudace molecule expressed on activated endothelial cells, ~s 
=mphcatod m the yon/oarly stagos oi athor0sctorosis by mediating adhesion 
of leukocytos fo ondotholium. The aim ot this study was to evaluate the 
effect of a calcium antagonist isradipin0 SRO and a h-imidazoline agonist 
moxonidino on plasma levels of soluble E-Seloctin (sE-Sol) proposed as 
marker of early endothelial dysfuncben 
Methods: Fifty two patients (pts) with mild to moderato hypertension, 
dtwded in two groups (group A: 24 pt8 treated by isredipino SRO, 4 mg daily 
and group B: 28 pts treated by moxomdine. 0.4 mg daily) were evaluated for 
hepanne plasma levels of sE-SeI, measured by ELISA. before and after four 
months of therapy and compared to 31 age and sex matched controls. Before 
tr.atment groups A and B did nat differ in any of systolic and diastolic blood 
pressure (SBP and DBP, respectively), ago, body mass index, left ventricular 
mass index or total penpheral resistances. 
Results: The results are summanzed in the following table: 
Paramotm Controls Group A Group B 
sE-Sol (ng/mL) before 236 t 1 8 379 ± 29' 362 ¢ 28' 
after 325 ~ 2i" ~" 37.1 "~ 3 "~ * 
% \ 119 ± 41 2 5 :~ 1.5 
SBP m~mHg) before 114 2 *. 1 3 1576 r 3 ~' 161 4 z 39' 
alter 123.6 ± 3,9 = 133,1 ~- 2.1 ",A 
%A 214 ~_ 2 7 17.1 ± 1,8 
DBP (mrnHg) bolero 80 1 ~. 2.3 102 ± 13" 10,1 .t_ 1.1' 
after 802 ± 2.1 • 86,4 ± 0.7 • 
%~' 213 ± 2 147 ± 0,9 
t) % "=: percent differences. 2) significanl differences (p • 0,05) in companson to COrre- 
sponding values: a) at controls ('). b) before the respective treatment ( • ) and c) after tire 
comparable treatment (') 
In group A, significant negative correlation was found between DBP before 
tre,ltmont ,and %A Of sE.$ol i;'la:~m,l Idylls (r = 0 7 ,  p ~ 003 )  Ne ~t~@r 
~gnfficant 00rr0kltlans w~r0 faun0, 
Cof~'lu~ton.e It ,s sugges:on m~t, ,n mild ta moderate nvpenon~on trover, 
meet w!tff grBdlpln,~ SRO may ~e mere ,~ffectwe_ than treatment w ~  m.~. 
Omdln~ tn regulating ~ndath~lllal C~11 functlan ~t I~'a~t ~3~ ~ro~l$1ng plasma11 
Io~ets 0t SE.Sel pra&"o~d a:~ mark0r o! ort~ot~eltal ~l~tunctlan and ~!~ is r~1 
r~lafed tO the eft~tweness at antihy~rtensive tr@~tt1~nt in ~ $ ! o ~  S~P 
or OBP In addition, i~radipino SRO treatment seems to P~J l e~  eftt~'~o ~n
decreasing plasm~ levels of ~E.$ol tar pt~t with h~gh OBP m~n rot those w~m 
low DBP l~tOm treatment 
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SevQr l t y?  
P Mas~al~u~'lu~ J Fouroede, M L~atinier, J M  Fau~.ei J P 8 0 ~ n ~ r e  
Ca~otegv R.~ng~i~ ~vqsp~taL ~ous~.  Y'~n~ 
Hy~L~..IR0ns!QI% iHT) iS a det0tm=nant fader of etherom~l! d~¢i"Opm~nt Tee 
a~m at fn~s stut.3y ¢,a~ to assess ~t there was a relationship E~tween ,~-lta 
el ~4 nour~ ameulalO~/ Dl~X~l p.~.tzu~ !ABP! ana se~ent~ of thoraCiC . ~  
tic atheroma in hyportensl~o I~lftonts We stuo~t~.l ¢~ ~at.ont~. ~44 men. 21 
¢~orheni, moan aged ~(~,2 ~ 11 4 ¥ear.~, ~lln f i t  and Past u~reOra! ~es. 
cu!ar event ABP re0ordmgs ¢~ere perton'ned ever~ 15 minutes aunng ~he 
day t o t  and 30 minutes duflng the night iN)  Atneroma was e~aK=ate~l t,,~ 
lransesophageal eeho~ardl~-~Jraphy We used a s~.~,nn O m ~ x  ~Sh ~r~luO- 
~ng the sum of plaque thickness tPT -.2 mm 2 to 4 9 mm ~:5 mini ,'a~l 
ddt~.,si.an number el ~n~alve~ aOrtiC segments ~as~n~lmg, honzonlai, ~ 
sc'ondmgl Porscstent HT ¢~as assessed on O and N n~ans ABP ac~'o~d~ng 
to Staosson's meta-analys~s O~pp~rs ~oro pabents who decreased syslo|< 
N - 10 and diastolic N ~ 5 ~reont~ Manovanate resultS: tho~ Was no r~  
lateen bob, roan PT or SI and sex, obesity, diabetes melhtus Age ~,~as re~ated 
tO PT (p = 000SI and St tP = 0 022! PT ~as more severe ~n persistent HT 
(p = 0 0~2t Multlvanata regresq~on mctud~nq aqe and moans ABP sho~ed 
an incre~se of SI and PT ~,~lth ago tb = *0 06 p = 003,  b = +0 ~ p = 0 01) 
d~astohc D ABP Ib = *032  p = 00008 b = +0 19 p = 0 0018t sysrc,!=c N AEIP 
(b = +017 p = 0 0008, b = *0 09 p = 0 0018~ and with ck',o'oase of s~.,stot~- D 
ABP tb = 0,21 p = 00005, b = 011 p = 0 002! and dlastohc N ABP (b = 0 
p = 00008. b = 0 16 p = 00009) Multwanate correlations SI r = 049. p = 
0 0065 and PT r = 0 49 p = 000S AdluStod means dippers.non dippe~ for 
SI 027 =: 045/2,52 ~ 027, p = 0 0006 and for PT 029  ,. 02& 1 45 ~ O 14 
p = 0 000S. In conclusion, ABP may be a marker at aorbc atheroma sewntv 
m pabents with hypertension 
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Background: We have previously reported that the raho beN~een stroke 
volume (SV, M-mode echocardtography, Telchholz') and pulse pressure tPP~ 
in adults is a measure of artenal compliance that is related directly to body 
weight and negatively to age and heart rate. by a multiple linear equation. 
which has been m-computed using a new validated method (z-denved) tar 
determination of M-mode volumes. 
Methods: The ratio of observed-to-predicted SV/PP (%ASV PP) was cal- 
culated in our reference population of 393 normal adults and the normal 95°0 
confidence interval was determined (71.6-139.3%~ %ASV/PP was com- 
puted in 491 hypertenswe patients (HPTS. 161 women. 228 overweight: 53 
r 10) and 537 normal controls (NOR. 224 women. 149 overweight: 46 : 12 
years, p - 00001). 
Results: Low %ASV/PP (-.71.6%t was present in 39 NOR (73%) and 
204 HPTS (41.5°o. p .  0.0001) In both NOR ~-- )  and HPTS ( ; ) ,  LV mass 
(LVM) was related to systolic pressure (r = 0.37 and 022) and. weakly, 
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